Skip to main navigation Skip to main content

CMH : Clinical and Molecular Hepatology

OPEN ACCESS
ABOUT
BROWSE ARTICLES
FOR CONTRIBUTORS

Page Path

3
results for

"Deep learning"

Article category

Keywords

Publication year

"Deep learning"

Editorial

Reviews

Steatotic liver disease

Non-invasive biomarkers for liver inflammation in non-alcoholic fatty liver disease: present and future
Terry Cheuk-Fung Yip, Fei Lyu, Huapeng Lin, Guanlin Li, Pong-Chi Yuen, Vincent Wai-Sun Wong, Grace Lai-Hung Wong
Clin Mol Hepatol 2023;29(Suppl):S171-S183.
Published online December 12, 2022
DOI: https://doi.org/10.3350/cmh.2022.0426
Inflammation is the key driver of liver fibrosis progression in non-alcoholic fatty liver disease (NAFLD). Unfortunately, it is often challenging to assess inflammation in NAFLD due to its dynamic nature and poor correlation with liver biochemical markers. Liver histology keeps its role as the standard tool, yet it is well-known for substantial sampling, intraobserver, and interobserver variability. Serum proinflammatory cytokines and apoptotic markers, namely cytokeratin-18, are well-studied with reasonable accuracy, whereas serum metabolomics and lipidomics have been adopted in some commercially available diagnostic models. Ultrasound and computed tomography imaging techniques are attractive due to their wide availability; yet their accuracies may not be comparable with magnetic resonance imaging-based tools. Machine learning and deep learning models, be they supervised or unsupervised learning, are promising tools to identify various subtypes of NAFLD, including those with dominating liver inflammation, contributing to sustainable care pathways for NAFLD.

Citations

Citations to this article as recorded by  Crossref logo
  • Deep learning-based automated detection of endometrioid endometrial carcinoma in histopathology
    Ruotong Li, Kunyu Zou, Qihang Ma, Yaping Liu, Xiaohui Wang, Wenbin Huang, Shegan Gao, Xueying Yang
    Frontiers in Oncology.2026;[Epub]     CrossRef
  • Diagnostic Performance of Shear-Wave Dispersion Slope for Biopsy-Proven Hepatic Inflammation in MASLD: A Systematic Review and HSROC Meta-Analysis
    Caixin Qiu, Meina Cai, Lulu Lyu, Peng Xu
    Ultrasound in Medicine & Biology.2026; 52(5): 916.     CrossRef
  • ROS-Responsive Prodrug Containing Dihydroartemisinin and Cinnamaldehyde for the Potential Treatment of Nonalcoholic Steatohepatitis
    Ru Hao, Yi Sun, Changyuan Wang, Yang Wang, Lei Li, Huijun Sun, Lixue Chen
    ACS Applied Materials & Interfaces.2026; 18(9): 13384.     CrossRef
  • Liver Injury Biomarkers in Pediatric Metabolic Syndrome: Key Biochemical Associations
    Teofana-Otilia Bizerea-Moga, Tudor Voicu Moga, Sanja Panic Zaric, Rade Vukovic, Otilia Mărginean, Lazăr Chișavu
    Metabolites.2026; 16(3): 171.     CrossRef
  • Potential Drug Targets and Causal Plasma Proteins Related to Preeclampsia Identified by Mendelian Randomization
    Wei Zhou, Ting Huang, Lei Li, Yanli Shen, Zhe Ji, Meng Yan
    Women's Health Reports.2026;[Epub]     CrossRef
  • Association between neutrophil-albumin ratio and ultrasound-defined metabolic dysfunction-associated fatty liver disease in U.S. adults: evidence from NHANES 2017–2018
    Ming-yu He, Xin-jie Du, Yi-ming Liu
    BMC Gastroenterology.2025;[Epub]     CrossRef
  • Mitochondrial mt12361A>G increased risk of metabolic dysfunction-associated steatotic liver disease among non-diabetes
    Ming-Ying Lu, Yu-Ju Wei, Chih-Wen Wang, Po-Cheng Liang, Ming-Lun Yeh, Yi-Shan Tsai, Pei-Chien Tsai, Yu-Min Ko, Ching-Chih Lin, Kuan-Yu Chen, Yi-Hung Lin, Tyng-Yuan Jang, Ming-Yen Hsieh, Zu-Yau Lin, Chung-Feng Huang, Jee-Fu Huang, Chia-Yen Dai, Wan-Long Ch
    World Journal of Gastroenterology.2025;[Epub]     CrossRef
  • Validation of the diagnostic accuracy of the acFibroMASH index for at-risk MASH in patients with metabolic dysfunction-associated steatotic liver disease
    Yunfei Wu, Yan Han, Liming Zheng, Longgen Liu, Wenjian Li, Fan Zhang
    BMC Gastroenterology.2025;[Epub]     CrossRef
  • Diagnostic Value of Serum Cytokeratin 18 for the Staging of Liver Inflammation and Fibrosis: A Meta‐Analysis
    Jinwen Chen, Jian Hu, Jialin Zhuang, Zhong Li, Se Peng, Xiaoting Huang, Jialing Zhuang
    Journal of Clinical Laboratory Analysis.2025;[Epub]     CrossRef
  • Obesity: pathophysiology and therapeutic interventions
    Yue Kong, Haokun Yang, Rong Nie, Xuxiang Zhang, Fan Zuo, Hongtao Zhang, Xin Nian
    Molecular Biomedicine.2025;[Epub]     CrossRef
  • Anti-inflammatory glycosides from Gomphandra mollis Merr.: Structural elucidation and mechanistic insights
    Quoc-Dung Tran Huynh, Thuy-Tien Thi Phan, Man-Hsiu Chu, Thanh-Vu Nguyen, Truc-Ly Thi Duong, Su-Jung Hsu, Yun-Han Wang, Ngoc-Thac Pham, Bien-Thuy Nguyen Bui, Dang-Khoa Nguyen, Thanh-Hoa Vo, Ta-Wei Liu, Ching-Kuo Lee
    Phytochemistry.2025; 239: 114583.     CrossRef
  • The advanced lung cancer inflammation index has an L-shaped association with prognosis in American adults with metabolic dysfunction-associated fatty liver disease: a cohort study
    Yuexia Lu, Shuaipeng Yuan, Huazhao Xu, Jiqi Ouyang, Jinsheng Dong, Xin Jiang, Xiao Shao, Runshun Zhang
    Frontiers in Nutrition.2025;[Epub]     CrossRef
  • Global Trends in Non-Invasive Techniques for the Diagnosis and Monitoring of Nonalcoholic Fatty Liver Disease: A Bibliometric and Visualization Analysis
    Jing-Wen Cai, Wei-Long Wang, Dong-Ling Lin, Shu-Feng Ren, Qian-Qian Jia, Xiao-Xuan He, Xue-Xia Yang, Wen Cai, Hui Hou
    Journal of Multidisciplinary Healthcare.2025; Volume 18: 4243.     CrossRef
  • Gradual DNA methylation changes reveal transcription factors implicated in metabolic dysfunction-associated steatotic liver disease progression and epigenetic age acceleration
    Evelien Van Dijck, Steven Van Laere, Emilie Logie, Steven Timmermans, Erik Fransen, Joe Ibrahim, Timothy J. Kendall, Jonathan A. Fallowfield, Ligia M. Mateiu, Claude Libert, Guy Van Camp, An Verrijken, Luc Van Gaal, Sven Francque, Wim Van Hul, Wim Vanden
    Clinical Epigenetics.2025;[Epub]     CrossRef
  • Quantification of 18F-FDG Delivery Rate for Liver Inflammation Using Shortened Dynamic PET Imaging Protocols
    Xiaoyu Duan, Souvik Sarkar, Victoria Lyo, Sean Romeo, Benjamin A. Spencer, Karen E. Matsukuma, Valentina Medici, Michael T. Corwin, Ramsey D. Badawi, Guobao Wang
    Journal of Nuclear Medicine.2025; 66(11): 1834.     CrossRef
  • ChatGPT improves usability, effectiveness, scalability, interpretability and accessibility, in early diagnosis of metabolic dysfunction-associated fatty liver disease
    Xiaoying Zhou, Zhipeng Gao, Han Ma, Jiahui Hu, Chengfu Xu, Zhe Shen, Miaomiao Tan, Chaohui Yu
    BMC Gastroenterology.2025;[Epub]     CrossRef
  • Low liver fat in non‐alcoholic steatohepatitis‐related significant fibrosis and cirrhosis is associated with hepatocellular carcinoma, decompensation and mortality
    Sung Won Lee, Daniel Q. Huang, Ricki Bettencourt, Veeral Ajmera, Monica Tincopa, Nabil Noureddin, Maral Amangurbanova, Harris Siddiqi, Egbert Madamba, Abdul M. Majzoub, Tarek Nayfeh, Nobuharu Tamaki, Namiki Izumi, Atsushi Nakajima, Masato Yoneda, Ramzan I
    Alimentary Pharmacology & Therapeutics.2024; 59(1): 80.     CrossRef
  • Neither hepatic steatosis nor fibrosis is associated with clinical outcomes in patients with intestinal Behçet’s disease
    Hye Kyung Hyun, Jihye Park, Soo Jung Park, Jae Jun Park, Tae Il Kim, Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Seung Up Kim, Jae Hee Cheon
    European Journal of Gastroenterology & Hepatology.2024; 36(4): 445.     CrossRef
  • Evolutive Models, Algorithms and Predictive Parameters for the Progression of Hepatic Steatosis
    Marinela Sînziana Tudor, Veronica Gheorman, Georgiana-Mihaela Simeanu, Adrian Dobrinescu, Vlad Pădureanu, Venera Cristina Dinescu, Mircea-Cătălin Forțofoiu
    Metabolites.2024; 14(4): 198.     CrossRef
  • Editorial: Inflammation and chronic disease
    Frank A. Orlando, Arch G. Mainous
    Frontiers in Medicine.2024;[Epub]     CrossRef
  • Advances in Noninvasive Molecular Imaging Probes for Liver Fibrosis Diagnosis
    Shaofang Chen, Danping Zhuang, Qingyun Jia, Bing Guo, Genwen Hu
    Biomaterials Research.2024;[Epub]     CrossRef
  • Serum Cytokeratin-18 levels as a prognostic biomarker in advanced liver disease: a comprehensive meta-analysis
    Xin Zhang, Jiangguo Li, Li Jiang, Yuexia Deng, Licheng Wei, Xing Li
    Clinical and Experimental Medicine.2024;[Epub]     CrossRef
  • The Metabolomic Footprint of Liver Fibrosis
    Diren Beyoğlu, Yury V. Popov, Jeffrey R. Idle
    Cells.2024; 13(16): 1333.     CrossRef
  • Machine learning based identification potential feature genes for prediction of drug efficacy in nonalcoholic steatohepatitis animal model
    Marwa Matboli, Ibrahim Abdelbaky, Abdelrahman Khaled, Radwa Khaled, Shaimaa Hamady, Laila M. Farid, Mariam B. Abouelkhair, Noha E. El-Attar, Mohamed Farag Fathallah, Manal S. Abd EL Hamid, Gena M. Elmakromy, Marwa Ali
    Lipids in Health and Disease.2024;[Epub]     CrossRef
  • Structure-function analysis of time-resolved immunological phases in metabolic dysfunction-associated fatty liver disease (MASH) comparing the NIF mouse model to human MASH
    Anja Schmidt-Christensen, Gustaw Eriksson, William M. Laprade, Behnaz Pirzamanbein, Maria Hörnberg, Kajsa Linde, Julia Nilsson, Mark Skarsfeldt, Diana J. Leeming, Rajmund Mokso, Mariana Verezhak, Anders Dahl, Vedrana Dahl, Kristina Önnerhag, Massoud Rezae
    Scientific Reports.2024;[Epub]     CrossRef
  • Polygala japonica Houtt.: A comprehensive review on its botany, traditional uses, phytochemistry, pharmacology, and pharmacokinetics
    Hai-Peng Tang, En-Lin Zhu, Qian-Xiang Bai, Shuang Wang, Zhi-Bin Wang, Meng Wang, Hai-Xue Kuang
    Fitoterapia.2024; 179: 106233.     CrossRef
  • Chondroitin Sulfate from Halaelurus burgeri Skin Inhibits Hepatic Endoplasmic Reticulum Stress and Inflammation, and Regulates Gut Microbiota
    Zhaocai Ren, Shang Gao, Shiwei Hu, Sichun Chen, Wei Jiang, Yaming Ge
    Molecular Nutrition & Food Research.2024;[Epub]     CrossRef
  • Serum Cytokeratin 18 Fragment Is an Indicator for Treating Metabolic Dysfunction-Associated Steatotic Liver Disease
    Miwa Kawanaka, Yoshihiro Kamada, Hirokazu Takahashi, Michihiro Iwaki, Ken Nishino, Wenli Zhao, Yuya Seko, Masato Yoneda, Yoshihito Kubotsu, Hideki Fujii, Yoshio Sumida, Hirofumi Kawamoto, Yoshito Itoh, Atsushi Nakajima, Takeshi Okanoue, Takumi Kawaguchi,
    Gastro Hep Advances.2024; 3(8): 1120.     CrossRef
  • Metabolomic Hallmarks of Obesity and Metabolic Dysfunction-Associated Steatotic Liver Disease
    Diren Beyoğlu, Yury V. Popov, Jeffrey R. Idle
    International Journal of Molecular Sciences.2024; 25(23): 12809.     CrossRef
  • MASLD: predictive value for liver-related events and extra-hepatic complications
    Mohamad Jamalinia, Amedeo Lonardo
    Expert Review of Gastroenterology & Hepatology.2024; 18(11): 685.     CrossRef
  • Baseline Tyrosine Level Is Associated with Dynamic Changes in FAST Score in NAFLD Patients under Lifestyle Modification
    Hwi Young Kim, Da Jung Kim, Hye Ah Lee, Joo-Youn Cho, Won Kim
    Metabolites.2023; 13(3): 444.     CrossRef
  • Prospective direct comparison of non‐invasive liver tests in outpatients with type 2 diabetes using intention‐to‐diagnose analysis
    Thierry Poynard, Olivier Deckmyn, Valentina Peta, Valérie Paradis, Jean‐Francois Gautier, Angélique Brzustowski, Pierre Bedossa, Laurent Castera, Stanislas Pol, Dominique Valla
    Alimentary Pharmacology & Therapeutics.2023; 58(9): 888.     CrossRef
  • 11,673 View
  • 346 Download
  • 33 Web of Science
  • Crossref
Deep learning-based prediction of molecular cancer biomarkers from tissue slides: A new tool for precision oncology
Sung Hak Lee, Hyun-Jong Jang
Clin Mol Hepatol 2022;28(4):754-772.
Published online April 21, 2022
DOI: https://doi.org/10.3350/cmh.2021.0394
Molecular tests are necessary to stratify cancer patients for targeted therapy. However, high cost and technical barriers limit the application of these tests, hindering optimal treatment. Recently, deep learning (DL) has been applied to predict molecular test results from digitized images of tissue slides. Furthermore, treatment response and prognosis can be predicted from tissue slides using DL. In this review, we summarized DL-based studies regarding the prediction of genetic mutation, microsatellite instability, tumor mutational burden, molecular subtypes, gene expression, treatment response, and prognosis directly from hematoxylin- and eosin-stained tissue slides. Although performance needs to be improved, these studies clearly demonstrated the feasibility of DL-based prediction of key molecular features in cancer tissues. With the accumulation of data and technical advances, the performance of the DL system could be improved in the near future. Therefore, we expect that DL could provide cost- and time-effective alternative tools for patient stratification in the era of precision oncology.

Citations

Citations to this article as recorded by  Crossref logo
  • Deep learning-driven morphological analysis for assessing EMT state and drug sensitivity of single tumor cell
    Yiyao Yang, Yuxin Guo, Zhaoliang Wang, Yifan Weng, Tingting Hao, Qingqing Zhang, Shuihua Wang, Zhiyong Guo
    Biosensors and Bioelectronics.2026; 291: 118051.     CrossRef
  • Organ cross-talk: molecular mechanisms, biological functions, and therapeutic interventions for diseases
    Huiting Che, Yidan Gao, Yonghu Xu, Hui Xu, Roland Eils, Mei Tian
    Signal Transduction and Targeted Therapy.2026;[Epub]     CrossRef
  • What if Every Patient’s Immune System Could be Guided by the World’s Most Powerful Computers to Fight Cancer? The UK Cancer Vaccines AI and Supercompute Project
    Michael E. Bryan, Joseph Conway, Gareth Bloomfield, Aska Matsunaga, David Narganes-Carlon, Ian Lowenhoff, Nick K. Davis, Justin K.H. Liu, Qamar Ghafoor, Michael Tilby, Michael Rowe, Isabella Watts, Sam Khan, Rene Roux, Kristen Dahlgren, Matt Hancock, Elis
    EMJ Innovation.2026;[Epub]     CrossRef
  • Understanding liver and digestive diseases: a paved road to improve diagnosis, management, and treatment
    Ina Bergheim, Jean Francois Cadranel, Jianguo Chen, Wenxing Ding, Robert Eferl, Carmen Garcia-Ruiz, Hartmut Jaeschke, Firouzeh Kazerouni, Amedeo Lonardo, Derek A. Mann, Nahum Méndez-Sánchez, Camelia Mokhtari, Han Moshage, Chiara Raggi, Pavel Strnad, Oren
    Exploration of Digestive Diseases.2026;[Epub]     CrossRef
  • PH2ST: Prompt-guided hypergraph learning for spatial transcriptomics prediction in whole slide images
    Yi Niu, Jiashuai Liu, Yingkang Zhan, Jiangbo Shi, Di Zhang, Marika Reinius, Ines Machado, Mireia Crispin-Ortuzar, Jialun Wu, Chen Li, Zeyu Gao
    Medical Image Analysis.2026; 110: 104008.     CrossRef
  • Deep Learning Enables Pixel-Level Nanoparticle Distribution Mapping in Routine Histological Sections by Integrating Cancer Associated Fibroblasts Features
    Xin Pan, Linwen Lv, Jiayi Wang, Haojun Liang, Jiaxin Wan, Junhui Zhang, Ruyu Yan, Juan Li, Ya-nan Chang, Xue Bai, Lu Zhang, Gengmei Xing, Kui Chen
    ACS Nano.2026;[Epub]     CrossRef
  • Deep learning-based image analysis in muscle histopathology using photo-realistic synthetic data
    Leonid Mill, Oliver Aust, Jochen A. Ackermann, Philipp Burger, Monica Pascual, Katrin Palumbo-Zerr, Gerhard Krönke, Stefan Uderhardt, Georg Schett, Christoph S. Clemen, Christian Holtzhausen, Samir Jabari, Rolf Schröder, Andreas Maier, Anika Grüneboom
    Communications Medicine.2025;[Epub]     CrossRef
  • Deep Learning–Powered Whole Slide Image Analysis in Cancer Pathology
    Chengrun Dang, Zhuang Qi, Tao Xu, Mingkai Gu, Jiajia Chen, Jie Wu, Yuxin Lin, Xin Qi
    Laboratory Investigation.2025; 105(7): 104186.     CrossRef
  • Recent advances and challenges in colorectal cancer: From molecular research to treatment
    Gao-Xiu Qi, Rui-Xia Zhao, Chen Gao, Zeng-Yan Ma, Shang Wang, Jing Xu
    World Journal of Gastroenterology.2025;[Epub]     CrossRef
  • Deep Learning Model-Based Architectures for Lung Tumor Mutation Profiling: A Systematic Review
    Samanta Ortuño-Miquel, Reyes Roca, Cristina Alenda, Francisco Aranda, Natividad Martínez-Banaclocha, Sandra Amador, David Gil
    Cancers.2025; 17(22): 3619.     CrossRef
  • AI-Driven Digital Pathology: Deep Learning and Multimodal Integration for Precision Oncology
    Hyun-Jong Jang, Sung Hak Lee
    International Journal of Molecular Sciences.2025; 27(1): 379.     CrossRef
  • Training immunophenotyping deep learning models with the same-section ground truth cell label derivation method improves virtual staining accuracy
    Abu Bakr Azam, Felicia Wee, Juha P. Väyrynen, Willa Wen-You Yim, Yue Zhen Xue, Bok Leong Chua, Jeffrey Chun Tatt Lim, Aditya Chidambaram Somasundaram, Daniel Shao Weng Tan, Angela Takano, Chun Yuen Chow, Li Yan Khor, Tony Kiat Hon Lim, Joe Yeong, Mai Chan
    Frontiers in Immunology.2024;[Epub]     CrossRef
  • Correspondence to editorial on “Multiomics profiling of buffy coat and plasma unveils etiology-specific signatures in hepatocellular carcinoma”
    Su Bin Lim, Hyo Jung Cho
    Clinical and Molecular Hepatology.2024; 30(4): 1009.     CrossRef
  • Integrating transcriptomic data and digital pathology for NRG-based prediction of prognosis and therapy response in gastric cancer
    Qiuyan Sun, Tan Li, Zheng Wei, Zhiyi Ye, Xu Zhao, Jingjing Jing
    Annals of Medicine.2024;[Epub]     CrossRef
  • Development and validation of a prognostic nomogram including inflammatory indicators for overall survival in hepatocellular carcinoma patients treated primarily with surgery or loco-regional therapy: A single-center retrospective study
    Xin Wang, Jing Xu, Zhenya Jia, Guoping Sun
    Medicine.2024; 103(50): e40889.     CrossRef
  • Deep learning captures selective features for discrimination of microsatellite instability from pathologic tissue slides of gastric cancer
    Sung Hak Lee, Yujin Lee, Hyun‐Jong Jang
    International Journal of Cancer.2023; 152(2): 298.     CrossRef
  • A Single Nucleotide Polymorphism rs1010816 Predicts Sorafenib Therapeutic Outcomes in Advanced Hepatocellular Carcinoma
    Chih-Lang Lin, Kung-Hao Liang, Ching-Chih Hu, Cheng-Hung Chien, Li-Wei Chen, Rong-Nan Chien, Yang-Hsiang Lin, Chau-Ting Yeh
    International Journal of Molecular Sciences.2023; 24(2): 1681.     CrossRef
  • Association between Biomarkers (VEGF-R2, VEGF-R3, VCAM-1) and Treatment Duration in Patients with Neuroendocrine Tumors Receiving Therapy with First-Generation Somatostatin Analogues
    Violetta Rosiek, Ksenia Janas, Beata Kos-Kudła
    Biomedicines.2023; 11(3): 842.     CrossRef
  • Development and validation of prognostic nomograms for large hepatocellular carcinoma after HAIC
    Wang Yao, Ran Wei, Jia Jia, Wang Li, Mengxuan Zuo, Shuqing Zhuo, Ge Shi, Peihong Wu, Chao An
    Therapeutic Advances in Medical Oncology.2023;[Epub]     CrossRef
  • High-content microscopy reveals a morphological signature of bortezomib resistance
    Megan E Kelley, Adi Y Berman, David R Stirling, Beth A Cimini, Yu Han, Shantanu Singh, Anne E Carpenter, Tarun M Kapoor, Gregory P Way
    eLife.2023;[Epub]     CrossRef
  • Deep Learning-Based Classification of Uterine Cervical and Endometrial Cancer Subtypes from Whole-Slide Histopathology Images
    JaeYen Song, Soyoung Im, Sung Hak Lee, Hyun-Jong Jang
    Diagnostics.2022; 12(11): 2623.     CrossRef
  • Deep Learning-Based Prediction of Molecular Tumor Biomarkers from H&E: A Practical Review
    Heather D. Couture
    Journal of Personalized Medicine.2022; 12(12): 2022.     CrossRef
  • 10,874 View
  • 276 Download
  • 22 Web of Science
  • Crossref